Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 27.

Roider, E; Signer, C; Fehrenbacher, B; Metzler, G; Schaller, M; Kamarachev, J; Kerl, K; Balabanov, S; Jochum, W; Hoetzenecker, W; Cozzio, A; French, L; Dummer, R; Guenova, E (2018). Individualized treatment approaches for Langerhans cell histiocytosis. British Journal of Dermatology, 178(6):1423-1424.

Widmer, F; Balabanov, S; Soldini, D; Samaras, P; Gerber, B; Manz, M G; Goede, J G (2018). R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. Annals of Hematology, 97(2):277-287.

Widmer, C C; Balabanov, S; Schanz, U; Theocharides, A (2017). Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease. OncoTarget, 8(63):106333-106341.

Dyshlovoy, S A; Menchinskaya, E S; Venz, S; Rast, S; Amann, K; Hauschild, J; Otte, K; Kalinin, V I; Silchenko, A S; Avilov, S A; Alsdorf, W; Madanchi, R; Bokemeyer, C; Schumacher, U; Walther, R; Aminin, D L; Fedorov, S N; Shubina, L K; Stonik, V A; Balabanov, S; Honecker, F; von Amsberg, G (2016). The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. International Journal of Cancer, 138(10):2450-2465.

Dyshlovoy, S A; Venz, S; Hauschild, J; Tabakmakher, K M; Otte, K; Madanchi, R; Walther, R; Guzii, A G; Makarieva, T N; Shubina, L K; Fedorov, S N; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F; V Amsberg, G (2016). Anti-migratory activity of marine alkaloid monanchocidin A : proteomics-based discovery and confirmation. Proteomics, 16(10):1590-1603.

Weidner, C I; Lin, Q; Birkhofer, C; Gerstenmaier, U; Kaifie, A; Kirschner, M; Bruns, H; Balabanov, S; Trummer, A; Stockklausner, C; Höchsmann, B; Schrezenmeier, H; Wlodarski, M; Panse, J; Brümmendorf, T H; Beier, F; Wagner, W (2016). DNA methylation in PRDM8 is indicative for dyskeratosis congenita. OncoTarget, 7(10):10765-10772.

Werner, B; Beier, F; Hummel, S; Balabanov, S; Lassay, L; Orlikowsky, T; Dingli, D; Brümmendorf, T H; Traulsen, A (2015). Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions. eLife, 4:e08687.

Dyshlovoy, S A; Hauschild, J; Amann, K; Tabakmakher, K M; Venz, S; Walther, R; Guzii, A G; Makarieva, T N; Shubina, L K; Fedorov, S N; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F; von Amsberg, G (2015). Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization. OncoTarget, 6(19):17328-17341.

Ummanni, R; Duscharla, D; Barett, C; Venz, S; Schlomm, T; Heinzer, H; Walther, R; Bokemeyer, C; Brümmendorf, T H; Murthy, P V; Balabanov, S (2015). Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics, 119:218-229.

Niegisch, G; Retz, M; Thalgott, M; Balabanov, S; Honecker, F; Ohlmann, C H; Stöckle, M; Bögemann, M; Vom Dorp, F; Gschwend, J; Hartmann, A; Ohmann, C; Albers, P (2015). Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09). Oncology, 89(2):70-78.

Honecker, F; Rohlfing, T; Harder, S; Braig, M; Gillis, A J; Glaesener, S; Barett, C; Bokemeyer, C; Buck, F; Brümmendorf, T H; Looijenga, L H; Balabanov, S (2014). Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. Journal of Proteomics, 96:300-313.

Dyshlovoy, S A; Venz, S; Shubina, L K; Fedorov, S N; Walther, R; Jacobson, C; Stonik, V A; Bokemeyer, C; Balabanov, S; Honecker, F (2014). Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer. Journal of Proteomics, 96:223-239.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Wellbrock, J; Sheikhzadeh, S; Oliveira-Ferrer, L; Stamm, H; Hillebrand, M; Keyser, B; Klokow, M; Vohwinkel, G; Bonk, V; Otto, B; Streichert, T; Balabanov, S; Hagel, C; Rybczynski, M; Bentzien, F; Bokemeyer, C; von Kodolitsch, Y; Fiedler, W (2014). Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: Implications on pathophysiology and early disease detection. PLoS ONE, 9(8):e104742.

Lohmann, F; Sachs, M; Meyer, T N; Sievert, H; Lindenmeyer, M T; Wiech, T; Cohen, C D; Balabanov, S; Stahl, R A; Meyer-Schwesinger, C (2014). UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation. BBA - Biochimica et Biophysica Acta, 1842(7):945-958.

Balabanov, S; Braig, M; Brümmendorf, T H (2014). Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia. Drug Discovery Today: Technologies, 11:89-99.

Sievert, H; Pällmann, N; Miller, K K; Hermanns-Borgmeyer, I; Venz, S; Sendoel, A; Preukschas, M; Schweizer, M; Boettcher, S; Janiesch, P C; Streichert, T; Walther, R; Hengartner, M O; Manz, M G; Brümmendorf, T H; Bokemeyer, C; Braig, M; Hauber, J; Duncan, K E; Balabanov, S (2014). A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation. Disease Models & Mechanisms, 7(8):963-976.

Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brümmendorf, T H; Schuppert, A (2013). Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors. PLoS ONE, 8(1):e53668.

Martens, T; Matschke, J; Müller, C; Riethdorf, S; Balabanov, S; Westphal, M; Heese, O (2013). Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases. Clinical Neurology and Neurosurgery, 115(3):323-328.

Ziegler, P; Chahoud, T; Wilhelm, T; Pällmann, N; Braig, M; Wiehle, V; Ziegler, S; Schröder, M; Meier, C; Kolodzik, A; Rarey, M; Panse, J; Hauber, J; Balabanov, S; Brümmendorf, T H (2012). Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias. Investigational New Drugs, 30(6):2274-2283.

Sievert, H; Venz, S; Platas-Barradas, O; Dhople, V M; Schaletzky, M; Nagel, C H; Braig, M; Preukschas, M; Pällmann, N; Bokemeyer, C; Brümmendorf, T H; Pörtner, R; Walther, R; Duncan, K E; Hauber, J; Balabanov, S (2012). Protein-protein-interaction network organization of the hypusine modification system. Molecular & Cellular Proteomics, 11(11):1289-1305.

Meyer-Schwesinger, C; Dehde, S; Sachs, M; Mathey, S; Arefi, K; Gatzemeier, S; Balabanov, S; Becker, J U; Thaiss, F; Meyer, T N (2012). Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. American Journal of Physiology. Renal Physiology, 303(7):F1015-F1025.

Preukschas, M; Hagel, C; Schulte, A; Weber, K; Lamszus, K; Sievert, H; Pällmann, N; Bokemeyer, C; Hauber, J; Braig, M; Balabanov, S (2012). Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS ONE, 7(8):43468.

Ziegler, P; Schrezenmeier, H; Akkad, J; Brassat, U; Vankann, L; Panse, J; Wilop, S; Balabanov, S; Schwarz, K; Martens, U M; Brümmendorf, T H (2012). Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Annals of Hematology, 91(7):1115-1120.

Ummanni, R; Barreto, F; Venz, S; Scharf, C; Barett, C; Mannsperger, H A; Brase, J C; Kuner, R; Schlomm, T; Sauter, G; Sültmann, H; Korf, U; Bokemeyer, C; Walther, R; Brümmendorf, T H; Balabanov, S (2012). Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. Journal of Proteome Research, 11(4):2452-2466.

Dyshlovoy, S A; Naeth, I; Venz, S; Preukschas, M; Sievert, H; Jacobsen, C; Shubina, L K; Gesell Salazar, M; Scharf, C; Walther, R; Krepstakies, M; Priyadarshini, P; Hauber, J; Fedorov, S N; Bokemeyer, C; Stonik, V A; Balabanov, S; Honecker, F (2012). Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. Journal of Proteome Research, 11(4):2316-2330.

Nitzsche, B; Gloesenkamp, C; Schrader, M; Hoffmann, B; Zengerling, F; Balabanov, S; Honecker, F; Höpfner, M (2012). Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. British Journal of Cancer, 107(11):1853-1863.

This list was generated on Mon Feb 18 01:31:06 2019 CET.